[Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].
Identifieur interne : 000D36 ( Ncbi/Merge ); précédent : 000D35; suivant : 000D37[Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].
Auteurs : Z W Zhu [République populaire de Chine] ; J J Tang [République populaire de Chine] ; X P Chai [République populaire de Chine] ; Z F Fang [République populaire de Chine] ; Q M Liu [République populaire de Chine] ; X Q Hu [République populaire de Chine] ; D Y Xu [République populaire de Chine] ; L. Tang [République populaire de Chine] ; S. Tai [République populaire de Chine] ; Y Z Wu [République populaire de Chine] ; S H Zhou [République populaire de Chine]Source :
- Zhonghua xin xue guan bing za zhi [ 0253-3758 ] ; 2020.
Abstract
Objective: To identify the characteristics including clinical features and pulmonary computed tomography (CT) features of heart failure and novel coronavirus pneumonia(COVID-19). Methods: This study was a retrospective study. A total of 7 patients with Heart failure and 12 patients with COVID-19 in the Second Xiangya Hospital of Central South University between December 1, 2019 and February 15, 2020 were enrolled. The baseline clinical and imaging features of the two groups were statistically analyzed. Results: There was no significant difference in age and sex between the two groups, but the incidence of epidemiological contact history, fever or respiratory symptoms in the COVID-19 group was significantly higher than that in the heart failure group (12/12 vs. 2/7, P=0.001; 12/12 vs. 4/7, P<0.001). While the proportion of cardiovascular diseases and impaired cardiac function was significantly less than that of the heart failure group(2/12 vs.7/7, P<0.001; 0/12 vs.7/7, P<0.001). For imaging features, both groups had ground-glass opacity and thickening of interlobular septum, but the ratio of central and gradient distribution was higher in patients with heart failure than that in patients with COVID-19 (4/7 vs. 1/12, P=0.04). In heart failure group, the ratio of the expansion of small pulmonary veins was also higher (3/7 vs. 0, P=0.013), and the lung lesions can be significantly improved after effective anti-heart failure treatment. Besides, there are more disease with rounded morphology in COVID-19 (9/12 vs. 2/7, P=0.048) . Conclusions: More patients with COVID-19 have epidemiological history and fever or respiratory symptoms. There are significant differences in chest CT features, such as enlargement of pulmonary veins, lesions distribution and morphology between heart failure and COVID-19.
DOI: 10.3760/cma.j.cn112148-20200218-00093
PubMed: 32129583
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000841
- to stream PubMed, to step Curation: 000841
- to stream PubMed, to step Checkpoint: 000097
Links to Exploration step
pubmed:32129583Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].</title><author><name sortKey="Zhu, Z W" sort="Zhu, Z W" uniqKey="Zhu Z" first="Z W" last="Zhu">Z W Zhu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Tang, J J" sort="Tang, J J" uniqKey="Tang J" first="J J" last="Tang">J J Tang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Chai, X P" sort="Chai, X P" uniqKey="Chai X" first="X P" last="Chai">X P Chai</name><affiliation wicri:level="1"><nlm:affiliation>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Fang, Z F" sort="Fang, Z F" uniqKey="Fang Z" first="Z F" last="Fang">Z F Fang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Liu, Q M" sort="Liu, Q M" uniqKey="Liu Q" first="Q M" last="Liu">Q M Liu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Hu, X Q" sort="Hu, X Q" uniqKey="Hu X" first="X Q" last="Hu">X Q Hu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Xu, D Y" sort="Xu, D Y" uniqKey="Xu D" first="D Y" last="Xu">D Y Xu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Tang, L" sort="Tang, L" uniqKey="Tang L" first="L" last="Tang">L. Tang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Tai, S" sort="Tai, S" uniqKey="Tai S" first="S" last="Tai">S. Tai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Wu, Y Z" sort="Wu, Y Z" uniqKey="Wu Y" first="Y Z" last="Wu">Y Z Wu</name><affiliation wicri:level="1"><nlm:affiliation>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Zhou, S H" sort="Zhou, S H" uniqKey="Zhou S" first="S H" last="Zhou">S H Zhou</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32129583</idno><idno type="pmid">32129583</idno><idno type="doi">10.3760/cma.j.cn112148-20200218-00093</idno><idno type="wicri:Area/PubMed/Corpus">000841</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000841</idno><idno type="wicri:Area/PubMed/Curation">000841</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000841</idno><idno type="wicri:Area/PubMed/Checkpoint">000097</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000097</idno><idno type="wicri:Area/Ncbi/Merge">000D36</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].</title><author><name sortKey="Zhu, Z W" sort="Zhu, Z W" uniqKey="Zhu Z" first="Z W" last="Zhu">Z W Zhu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Tang, J J" sort="Tang, J J" uniqKey="Tang J" first="J J" last="Tang">J J Tang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Chai, X P" sort="Chai, X P" uniqKey="Chai X" first="X P" last="Chai">X P Chai</name><affiliation wicri:level="1"><nlm:affiliation>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Fang, Z F" sort="Fang, Z F" uniqKey="Fang Z" first="Z F" last="Fang">Z F Fang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Liu, Q M" sort="Liu, Q M" uniqKey="Liu Q" first="Q M" last="Liu">Q M Liu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Hu, X Q" sort="Hu, X Q" uniqKey="Hu X" first="X Q" last="Hu">X Q Hu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Xu, D Y" sort="Xu, D Y" uniqKey="Xu D" first="D Y" last="Xu">D Y Xu</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Tang, L" sort="Tang, L" uniqKey="Tang L" first="L" last="Tang">L. Tang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Tai, S" sort="Tai, S" uniqKey="Tai S" first="S" last="Tai">S. Tai</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Wu, Y Z" sort="Wu, Y Z" uniqKey="Wu Y" first="Y Z" last="Wu">Y Z Wu</name><affiliation wicri:level="1"><nlm:affiliation>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author><author><name sortKey="Zhou, S H" sort="Zhou, S H" uniqKey="Zhou S" first="S H" last="Zhou">S H Zhou</name><affiliation wicri:level="1"><nlm:affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011</wicri:regionArea><wicri:noRegion>410011</wicri:noRegion></affiliation></author></analytic><series><title level="j">Zhonghua xin xue guan bing za zhi</title><idno type="ISSN">0253-3758</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><b>Objective:</b> To identify the characteristics including clinical features and pulmonary computed tomography (CT) features of heart failure and novel coronavirus pneumonia(COVID-19). <b>Methods:</b> This study was a retrospective study. A total of 7 patients with Heart failure and 12 patients with COVID-19 in the Second Xiangya Hospital of Central South University between December 1, 2019 and February 15, 2020 were enrolled. The baseline clinical and imaging features of the two groups were statistically analyzed. <b>Results:</b> There was no significant difference in age and sex between the two groups, but the incidence of epidemiological contact history, fever or respiratory symptoms in the COVID-19 group was significantly higher than that in the heart failure group (12/12 vs. 2/7, <i>P</i>=0.001; 12/12 vs. 4/7, <i>P</i><0.001). While the proportion of cardiovascular diseases and impaired cardiac function was significantly less than that of the heart failure group(2/12 vs.7/7, <i>P</i><0.001; 0/12 vs.7/7, <i>P</i><0.001). For imaging features, both groups had ground-glass opacity and thickening of interlobular septum, but the ratio of central and gradient distribution was higher in patients with heart failure than that in patients with COVID-19 (4/7 vs. 1/12, <i>P</i>=0.04). In heart failure group, the ratio of the expansion of small pulmonary veins was also higher (3/7 vs. 0, <i>P</i>=0.013), and the lung lesions can be significantly improved after effective anti-heart failure treatment. Besides, there are more disease with rounded morphology in COVID-19 (9/12 vs. 2/7, P=0.048) . <b>Conclusions:</b> More patients with COVID-19 have epidemiological history and fever or respiratory symptoms. There are significant differences in chest CT features, such as enlargement of pulmonary veins, lesions distribution and morphology between heart failure and COVID-19.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32129583</PMID><DateRevised><Year>2020</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0253-3758</ISSN><JournalIssue CitedMedium="Print"><Volume>48</Volume><Issue>0</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Zhonghua xin xue guan bing za zhi</Title><ISOAbbreviation>Zhonghua Xin Xue Guan Bing Za Zhi</ISOAbbreviation></Journal><ArticleTitle>[Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].</ArticleTitle><Pagination><MedlinePgn>E007</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3760/cma.j.cn112148-20200218-00093</ELocationID><Abstract><AbstractText><b>Objective:</b> To identify the characteristics including clinical features and pulmonary computed tomography (CT) features of heart failure and novel coronavirus pneumonia(COVID-19). <b>Methods:</b> This study was a retrospective study. A total of 7 patients with Heart failure and 12 patients with COVID-19 in the Second Xiangya Hospital of Central South University between December 1, 2019 and February 15, 2020 were enrolled. The baseline clinical and imaging features of the two groups were statistically analyzed. <b>Results:</b> There was no significant difference in age and sex between the two groups, but the incidence of epidemiological contact history, fever or respiratory symptoms in the COVID-19 group was significantly higher than that in the heart failure group (12/12 vs. 2/7, <i>P</i>=0.001; 12/12 vs. 4/7, <i>P</i><0.001). While the proportion of cardiovascular diseases and impaired cardiac function was significantly less than that of the heart failure group(2/12 vs.7/7, <i>P</i><0.001; 0/12 vs.7/7, <i>P</i><0.001). For imaging features, both groups had ground-glass opacity and thickening of interlobular septum, but the ratio of central and gradient distribution was higher in patients with heart failure than that in patients with COVID-19 (4/7 vs. 1/12, <i>P</i>=0.04). In heart failure group, the ratio of the expansion of small pulmonary veins was also higher (3/7 vs. 0, <i>P</i>=0.013), and the lung lesions can be significantly improved after effective anti-heart failure treatment. Besides, there are more disease with rounded morphology in COVID-19 (9/12 vs. 2/7, P=0.048) . <b>Conclusions:</b> More patients with COVID-19 have epidemiological history and fever or respiratory symptoms. There are significant differences in chest CT features, such as enlargement of pulmonary veins, lesions distribution and morphology between heart failure and COVID-19.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Z W</ForeName><Initials>ZW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>X P</ForeName><Initials>XP</Initials><AffiliationInfo><Affiliation>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Z F</ForeName><Initials>ZF</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Q M</ForeName><Initials>QM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>X Q</ForeName><Initials>XQ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>D Y</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Y Z</ForeName><Initials>YZ</Initials><AffiliationInfo><Affiliation>Emergency Depratment, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>S H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Xiangya Hospital of Central South University, Changsha, 410011, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>chi</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Zhonghua Xin Xue Guan Bing Za Zhi</MedlineTA><NlmUniqueID>7910682</NlmUniqueID><ISSNLinking>0253-3758</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="chi"><AbstractText><b>目的：</b> 对比心力衰竭及新型冠状病毒肺炎（COVID-19）患者临床及肺部影像学特征，总结二者的鉴别要点。 <b>方法：</b> 本研究为回顾性研究。纳入中南大学湘雅二医院于2019年12月1日至2020年2月15日间收治的心力衰竭及COVID-19患者，排除病例资料不全者，共纳入心力衰竭患者7例，COVID-19患者12例。比较两组的基线临床特征（包括性别、年龄、病史、实验室检查等）及肺部CT影像学特征。 <b>结果：</b> 两组间年龄、性别差异无统计学意义，COVID-19组流行病学接触史、发热或呼吸道症状比例明显高于心力衰竭组（12/12比2/7，<i>P</i>=0.001；12/12比4/7，<i>P</i><0.001）；合并心血管基础疾病、心功能受损比例则明显少于心力衰竭组（2/12比7/7，<i>P</i><0.001；0比7/7，<i>P</i><0.001）。影像学方面，两组患者都可有磨玻璃影及小叶间隔增厚的特点。但与COVID-19组比较，心力衰竭患者肺部病变呈中央型及阶梯状的比例（4/7比1/12，<i>P</i>=0.04）及小肺静脉扩张比例更高（3/7比0，<i>P</i>=0.013），且经有效抗心力衰竭治疗后肺部病变会明显快速改善。此外，COVID-19患者肺部病变圆形或类圆形的比例高于心衰患者（9/12比2/7，<i>P</i>=0.048）。 <b>结论：</b> COVID-19患者流行病学接触史，发热和呼吸道症状明显。在肺部CT影像学表现上，二者有相似之处，但病变分布特点、病变形态和肺静脉扩张情况有不同之处。.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Pulmonary computed tomography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32129583</ArticleId><ArticleId IdType="doi">10.3760/cma.j.cn112148-20200218-00093</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>République populaire de Chine</li></country></list><tree><country name="République populaire de Chine"><noRegion><name sortKey="Zhu, Z W" sort="Zhu, Z W" uniqKey="Zhu Z" first="Z W" last="Zhu">Z W Zhu</name></noRegion><name sortKey="Chai, X P" sort="Chai, X P" uniqKey="Chai X" first="X P" last="Chai">X P Chai</name><name sortKey="Fang, Z F" sort="Fang, Z F" uniqKey="Fang Z" first="Z F" last="Fang">Z F Fang</name><name sortKey="Hu, X Q" sort="Hu, X Q" uniqKey="Hu X" first="X Q" last="Hu">X Q Hu</name><name sortKey="Liu, Q M" sort="Liu, Q M" uniqKey="Liu Q" first="Q M" last="Liu">Q M Liu</name><name sortKey="Tai, S" sort="Tai, S" uniqKey="Tai S" first="S" last="Tai">S. Tai</name><name sortKey="Tang, J J" sort="Tang, J J" uniqKey="Tang J" first="J J" last="Tang">J J Tang</name><name sortKey="Tang, L" sort="Tang, L" uniqKey="Tang L" first="L" last="Tang">L. Tang</name><name sortKey="Wu, Y Z" sort="Wu, Y Z" uniqKey="Wu Y" first="Y Z" last="Wu">Y Z Wu</name><name sortKey="Xu, D Y" sort="Xu, D Y" uniqKey="Xu D" first="D Y" last="Xu">D Y Xu</name><name sortKey="Zhou, S H" sort="Zhou, S H" uniqKey="Zhou S" first="S H" last="Zhou">S H Zhou</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D36 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000D36 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:32129583
|texte= [Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:32129583" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |